About Glyco Biopharma
Glyco Biopharma is a Healthcare company based in Hyderabad (India) founded in 2018. It provides comprehensive solutions in feed supplements and antibiotics for poultry, aquaculture, and veterinary sectors. It operates on a B2B model. Its Indian entity Glyco Bio Pharma Private Limited reported revenue of ₹1.90 Cr. Its focus areas include Pharmaceuticals, Veterinary Medicine and Feed Supplements and Antibiotics.
Company details
Glyco Biopharma provides comprehensive solutions in feed supplements and antibiotics for poultry, aquaculture, and veterinary sectors through providing healthcare solutions, producing pharmaceutical products, veterinary medicine, and feed supplements and antibiotics. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.
- Headquarters Hyderabad, India
- SectorsHealthcare
- Email••••••••
- Website glycobiopharma.com
- Legal Name Glyco Bio Pharma Private Limited
- Date of Incorporation 28 Jun, 2017
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹1.90 Cr
FY 2024 · -22% YoY
- Net Profit₹3 Lakh
FY 2024 · 2% margin
- EBITDA₹10.8 Lakh
FY 2024 · 6% margin
Associated legal entities of Glyco Biopharma
Glyco Biopharma operates through Glyco Bio Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Glyco Bio Pharma Private Limited CIN U74999TG2017PTC117995 | Active | 28 Jun 2017 | Hyderabad, Telangana | ₹1.9 Cr | 1 | 2 | View details |
Board of directors of Glyco Bio Pharma Private Limited (Glyco Biopharma)
Glyco Bio Pharma Private Limited is the primary company behind Glyco Biopharma. The board of Glyco Bio Pharma Private Limited currently have 2 directors; the longest-serving is Sekhar Babu Mandava, appointed in 2017.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sekhar Babu Mandava DIN 07811951 | Director | 28 Jun 2017 | 9 yrs 4 mo | Glyco Bio Pharma Private Limited |
| Sujitha Sekharababu Mandava DIN 07812192 | Director | 28 Jun 2017 | 9 yrs 4 mo | Glyco Bio Pharma Private Limited |
Financials of Glyco Biopharma
Figures of Glyco Bio Pharma Private Limited, the primary company behind Glyco Biopharma, for FY 2024. Revenue was ₹1.90 Cr (-22% year on year). Net profit was ₹3 Lakh (2% margin). EBITDA was ₹10.8 Lakh (6% margin). Revenue has grown at a compounded annual rate of -9% over three years and +27% over five years.
- ₹1.90 CrRevenue · FY 2024 · -22% YoY
- ₹3 LakhNet profit · 2% margin
- ₹10.8 LakhEBITDA · 6% margin
- ₹1 LakhPaid-up capital
- 1Employees (provident fund records)
- -9%Revenue CAGR, 3 years
- +27%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Glyco Bio Pharma Private Limited are on its company page.
Detailed financial statements for Glyco Biopharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Glyco Biopharma
Glyco Biopharma was founded in 2018.
Glyco Biopharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind Glyco Biopharma, Glyco Bio Pharma Private Limited, reported revenue of ₹1.90 Cr for FY 2024, down 22% year on year.
Glyco Biopharma provides comprehensive solutions in feed supplements and antibiotics for poultry, aquaculture, and veterinary sectors through providing healthcare solutions, producing pharmaceutical products, veterinary medicine, and feed supplements and antibiotics. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.
Glyco Biopharma operates through Glyco Bio Pharma Private Limited.
The legal entities of Glyco Biopharma currently have 2 directors, including Sekhar Babu Mandava, Sujitha Sekharababu Mandava.